Bruton Tyrosine Kinase Degraders in B-Cell Malignancies

Mol Cancer Ther. 2024 May 2;23(5):619-626. doi: 10.1158/1535-7163.MCT-23-0520.
No abstract available

Publication types

  • Review

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase* / antagonists & inhibitors
  • Agammaglobulinaemia Tyrosine Kinase* / metabolism
  • B-Lymphocytes / metabolism
  • Humans
  • Leukemia, B-Cell / drug therapy
  • Leukemia, B-Cell / genetics
  • Leukemia, B-Cell / metabolism
  • Leukemia, B-Cell / pathology
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / metabolism
  • Lymphoma, B-Cell / pathology
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Protein-Tyrosine Kinases / genetics
  • Protein-Tyrosine Kinases / metabolism
  • Proteolysis

Substances

  • Agammaglobulinaemia Tyrosine Kinase
  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases